Archive
-
Video
Can You Trust the Experts?
Apr 10, 2024
Transparency and ethics are critical.
-
Partnership
The British Academy
The British Academy is the UK’s national academy for the humanities and social sciences. We mobilise these disciplines to understand the world and shape a brighter future.
-
Partnership
The AirNet
The Academic-Industry Research Network—theAIRnet—is a 501(c)(3) not-for-profit research organization devoted to the proposition that a sound understanding of the role of business in the economy requires collaboration between academic scholars and industry experts.
-
Partnership
SOAS University of London
SOAS is home to the leading research and expertise on the global issues of today.
-
Article
Bernanke and Blanchard’s Obsession with the Wage-Price Spiral
Apr 8, 2024
Bernanke and Blanchard have made another failed attempt to salvage establishment macroeconomics after the massive onslaught of adverse inflationary circumstances with which it could evidently not contend.
-
Working Paper
Working PaperTilting at Windmills: Bernanke and Blanchard’s Obsession with the Wage-Price Spiral
Apr 2024
How convincing is the model analysis by Bernanke and Blanchard? How empirically relevant are their mechanisms causing inflation – and how robust and plausible are their econometric findings?
-
Article
Europe's New Fiscal Rules Harm Working People and Women, Boost Right-Wing Radicals
Apr 5, 2024
Behind bogus promises of job creation and economic growth lies a dangerous agenda to shred social safety nets.
-
Video
The Medicare Maze
Apr 3, 2024
Your health shouldn’t be someone else’s wealth.
-
News
Rolling Stone cites Fred Ledley’s INET working paper on the NIH seed funding of pharmaceuticals
Mar 31, 2024
A Rolling Stone article by Andrew Perez cited Fred Ledley’s INET working paper on the NIH seed funding of pharmaceuticals.
-
Article
The Global Pharmaceutical Industry Isn’t Investing in Products for the Greatest Burden of Human Disease - Are Non-Profits a Solution?
Mar 29, 2024
Programs for expedited review may be preferentially reducing the development costs for conditions with lesser disease burden, potentially making investments in addressing the most significant disease burdens even less appealing and exacerbating the market failure further.
-
Video
Hysteresis and the Economy
Mar 27, 2024
Do temporary economic shocks like the COVID-19 recession create lasting effects on the economy?
-
Article
The European Union’s New Risk-Based Framework for Fiscal Rules – Overly Complex, Opaque and Self-Defeating
Mar 22, 2024
The discrepancy between technocratic rhetoric and economic facts is colossal.
-
Article
Experts: Negotiating Big Pharma's Prices Won't Stifle Innovation—They Don't Use the Money to Innovate!
Mar 14, 2024
Industry lobbyists vehemently oppose Medicare drug price negotiations. However, physician-scientist Fred Ledley and economist William Lazonick debunk their arguments.
-
Video
The Hidden Traps in Auto Loans
Mar 13, 2024
How the dark side of consumer finance prioritizes profit over people.
-
Video
Work, Retire, Repeat
Mar 6, 2024
The Uncertainty of Retirement in the New Economy